These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 10807300)

  • 41. [Hearing screening with evoked otoacoustic emission in the neonatal period are logistically and economically feasible].
    Díez-Delgado Rubio J; Espín Gálvez J; Lendinez Molinos F; Ortega Montes M MA; Arcos Martínez J; López Muñoz J
    An Esp Pediatr; 2002 Aug; 57(2):157-62. PubMed ID: 12139872
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Screening for congenital hearing loss--a pilot project].
    Kaldestad RH; Wingaard L; Hansen TW
    Tidsskr Nor Laegeforen; 2002 Sep; 122(22):2190-3. PubMed ID: 12426895
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An alternative strategy for universal infant hearing screening in tertiary hospitals with a high delivery rate, within a developing country, using transient evoked oto-acoustic emissions and brainstem evoked response audiometry.
    Mathur NN; Dhawan R
    J Laryngol Otol; 2007 Jul; 121(7):639-43. PubMed ID: 17112395
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Improving newborn hearing screening: Are automated auditory brainstem response ear inserts an effective option?
    Chan KT; Wong EC; Law CW; Chong HM; McPherson B
    Int J Pediatr Otorhinolaryngol; 2015 Nov; 79(11):1920-5. PubMed ID: 26412459
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Universal newborn hearing screening: methods and results, obstacles, and benefits.
    Wroblewska-Seniuk KE; Dabrowski P; Szyfter W; Mazela J
    Pediatr Res; 2017 Mar; 81(3):415-422. PubMed ID: 27861465
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Universal newborn hearing screening: are we achieving the Joint Committee on Infant Hearing (JCIH) objectives?
    Connolly JL; Carron JD; Roark SD
    Laryngoscope; 2005 Feb; 115(2):232-6. PubMed ID: 15689741
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Further examination of infants referred from newborn hearing screening.
    Wada T; Kubo T; Aiba T; Yamane H
    Acta Otolaryngol Suppl; 2004 Oct; (554):17-25. PubMed ID: 15513505
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neonates with congenital Cytomegalovirus and hearing loss identified via the universal newborn hearing screening program.
    Rawlinson WD; Palasanthiran P; Hall B; Al Yazidi L; Cannon MJ; Cottier C; van Zuylen WJ; Wilkinson M
    J Clin Virol; 2018 May; 102():110-115. PubMed ID: 29571077
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Benefits and costs of universal hearing screening programme.
    Cao-Nguyen MH; Kos MI; Guyot JP
    Int J Pediatr Otorhinolaryngol; 2007 Oct; 71(10):1591-5. PubMed ID: 17719096
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Universal Newborn Hearing Screening introduced to NICU infants in Canterbury Province, New Zealand.
    Flynn M; Austin N; Flynn TS; Ford R; Buckland L
    N Z Med J; 2004 Nov; 117(1206):U1183. PubMed ID: 15570352
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Implementing universal newborn hearing screening in the French Rhône-Alpes region. State of affairs in 2016 and the 1st half of 2017.
    Bouillot L; Vercherat M; Durand C
    Int J Pediatr Otorhinolaryngol; 2019 Feb; 117():30-36. PubMed ID: 30579084
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Volunteer-based universal newborn hearing screening program.
    Messner AH; Price M; Kwast K; Gallagher K; Forte J
    Int J Pediatr Otorhinolaryngol; 2001 Aug; 60(2):123-30. PubMed ID: 11518589
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A cost-effectiveness evaluation of newborn hemoglobinopathy screening from the perspective of state health care systems.
    Gessner BD; Teutsch SM; Shaffer PA
    Early Hum Dev; 1996 Jul; 45(3):257-75. PubMed ID: 8855399
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Potential costs and benefits of newborn screening for severe combined immunodeficiency.
    McGhee SA; Stiehm ER; McCabe ER
    J Pediatr; 2005 Nov; 147(5):603-8. PubMed ID: 16291349
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of two-step transient evoked otoacoustic emissions (TEOAE) and automated auditory brainstem response (AABR) for universal newborn hearing screening programs.
    Benito-Orejas JI; Ramírez B; Morais D; Almaraz A; Fernández-Calvo JL
    Int J Pediatr Otorhinolaryngol; 2008 Aug; 72(8):1193-201. PubMed ID: 18550180
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Infant hearing screening: effects of timeline.
    Tsui PW; McPherson B; Wong EC; Ng IH
    Clin Otolaryngol; 2008 Apr; 33(2):108-12. PubMed ID: 18429859
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effectiveness of population-based newborn hearing screening in England: ages of interventions and profile of cases.
    Uus K; Bamford J
    Pediatrics; 2006 May; 117(5):e887-93. PubMed ID: 16651292
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Congenital or Early Acquired Deafness: An Overview of the Portuguese Situation, from Diagnosis to Follow-Up].
    Oliveira C; Machado M; Zenha R; Azevedo L; Monteiro L; Bicho A
    Acta Med Port; 2019 Dec; 32(12):767-775. PubMed ID: 31851886
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Universal newborn hearing screening; automated transient evoked otoacoustic emissions.
    Arslan S; Işik AU; Imamoğlu M; Topbaş M; Aslan Y; Ural A
    B-ENT; 2013; 9(2):122-31. PubMed ID: 23909119
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Screening for hearing loss in newborns at Turku University Central Hospital].
    Sahlberg H; Salonen J; Jääskeläinen S; Lapinleimu H
    Duodecim; 2011; 127(18):1934-41. PubMed ID: 22034731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.